Vibrating Device For Treating Nasal Congestion and Sinusitis Symptoms and Method Thereof
Abstract
The present invention discloses a method of treating nasal congestion and/or relieving sinusitis symptoms in a patient comprising attaching a vibration generating means to the patient head, at a location adjacent to sinuses to be treated, generating a vibration by said vibration generating means, and delivering the same to said patient. The present invention also discloses a device for treating nasal congestion and/or relieving sinusitis symptoms in a patient, comprising attaching means and a vibration generating means; said attaching means are in communication with the patient's head in a location adjacent to said nasal cavity, nasal passageway or sinuses to be treated; said generating means are adapted to vibrate said attaching means, to vibrate the location adjacent to said nasal cavity or sinuses and thus improved mucociliary clearance of secretions in nasal cavity or sinuses.
Claims
exact text as granted — not AI-modified1 - 26 . (canceled)
27 . A method of treating nasal congestion and/or relieving sinusitis symptoms in a patient, comprising attaching a vibration generating means to the patient head, at a location adjacent to sinuses to be treated, generating a vibration by said vibration generating means, and delivering the same to said patient.
28 . The method according to claim 27 , wherein the body portions adjacent to nasal cavity, nasal passageway, sinus or sinuses of the patient are selected from the nasal bone, root-, dorsum- or bridge- of the nose, nostrils, frontal bone, temporal bone, maxilla bone, superciliary arch or any combination thereof.
29 . The method according to claim 27 , wherein delivering the vibration is applied by cycles of intermittent vibrations or pulses and/or by applying vibration of various amplitudes.
30 . The method according to claim 27 , additionally comprising pulsating a stream of fluid towards the patient's respiration tracts wherein the fluid is air or a mixture of air and at least one liquid or gas or powder.
31 . The method according to claim 30 , comprising vaporizing essential oils, volatile compounds, etheric oils, terepenes, terpanols and either water miscible or water-immiscible extracts, especially oils or extracts obtained from Amyris, Balsam, Bay Rum, Black Pepper, bornyl acetate, Cajeput, Camphor, Cedarwood, Cedarleaf oil, Chamomile, chlorbutanol, Cinnamon, Clary Sage Rosewood, Clove, Eucalyptus, Frankincense, Geranium, Ginger, Lavender, Lemon, Lemon essential oils, levomenthol, Lime, Menthol, Mint, Myrrh, nutmeg oil Orange, Patchouli, Peppermint, Pine Needle, Rose Eucalyptus, rosemary, Rosewood, Sage, Sandalwood, Spearmint, Tea Tree, terpinol, turpentine oil, thymol, Ylang Ylang or any combination thereof.
32 . The method according to claim 30 , comprising vaporizing at least one of the group of Braochodilators, especially sympatic mimetics, alfa antagonists, anti cholinergics; nasal decongestants, such as pseudoehedrines, ephedrines; steroids; anti histamines; anti prostaglandins, alternative or homeopathic medicaments; vaso constrictors; local anesthetics; mast cell stabilizers; antibiotics, such as biocides, fungicides etc; pleasant odor; pheromones; hormone treatments, such as ADH, insulin, growth hormones; vapors, humidifiers; drying compositions; hot or cold vapors; hyper-, iso- or hypotonic vapors or any combination thereof.
33 . The method according to claim 30 , comprising vaporizing at least one of the group of compositions and commercial available medicaments, their derivatives, or by-products provided thereof, selected from Acrivastine, Aller-Eze Clemastine, Aller-Eze nasal spray, Azatadine maleate, Azelastine nasal spray, Beclometasone nasal spray, Beclometasone nasal spray, Beconase hayfever nasal spray, Beconase hayfever relief for adults, Beconase nasal spray, Benadryl allergy relief, Benadryl, Benadryl, Benadryl plus, Brompheniramine maleate, Budesonide nasal spray, Calimal Antihistamine, Cetirizine, Chlorphenamine, Clarityn, Clemastine, Cyproheptadine hydrochloride, Desloratadine, Dexa-Rhinaspray Duo. Dimotane elixir, Dimotane plus, Dimotapp elixir, Dimotapp elixir paediatric. Dimotapp LA, Flixonase allergy nasal spray, Flixonase aqueous nasal spray, Fluticasone propionate nasal spray, Galpharm hayfever and allergy relief, Galpseud Plus, Haymine, Histafen, Ipratropium bromide nasal spray, Levocabastine nasal spray, Levocetirizine dihydrochloride, Livostin direct nasal spray, Livostin nasal spray, Loratadine, Medised, Medised, Mistamine, Mizolastine, Mizollen, Mometasone furoate nasal spray, Nasacort, Nasobec nasal spray, Nasonex nasal spray, Neoclarityn tablets/syrup, Optimine syrup, Periactin, Phenergan, Piriteze, Piriton, Pollenase hayfever nasal spray, Promethazine hydrochloride elixir, Promethazine hydrochloride, Rhinocort Aqua, Rhinolast allergy nasal spray, Rhinolast nasal spray, Rinatec nasal spray, Rino clenil nasal spray, Rynacrom allergy nasal spray, Rynacrom nasal spray, Semprex, Sodium cromoglicate nasal spray, Sudafed Plus, Syntaris nasal spray, Tavegil, Telfast 120, Terfenadine, Terfinax, Triamcinolone acetonide, Vista-Methasone, Xyzal tablets, Zirtek allergy relief tablets, Zirtek allergy tablets/solution, Afrazine, Anadin, Beechams all-in-one, Beechams products, Benylin products, Contac, Day Nurse, Dimotapp elixir, Dimotapp elixir paediatric, Dimotapp products, Galpseud, Karvol decongestant products, Lemsip products, Meggezones, Merocets Plus lozenges, Nurofen Cold and Flu, Otrivine Menthol Nasal Spray, Otrivine Metered Dose Sinusitis Spray, Otrivine products, Pseudoephedrine hydrochloride, Sterwin real lemon cold powders and other products, Strepsils Menthol and Eucalyptus and other products, Sudafed and its products, Xylometazoline nasal drops, Bactroban Nasal, Fusafungine, Locabiotal, Naseptin nasal cream, Ipratropium bromide nasal spray, Rinatec nasal spray, pseudoephedrine, propylhexedrine, L-Desoxyephedrine, xylometazoline hydrochloride or any combination thereof.
34 . The method according to claim 30 , additionally comprising cooling or heating said fluid before or in the process of forcing it towards the respiratory tracks.
35 . The method according to claim 30 , additionally comprising activating a medicament by reacting it with one or more reactants before or in the process of forcing the same towards the respiratory tracks.
36 . The method according to claim 30 , additionally comprising inhaling a dispersed medicament.
37 . A device for treating nasal congestion and/or relieving sinusitis symptoms in a patient, comprising attaching means and a vibration generating means; said attaching means are in communication with the patient's head in a location adjacent to said nasal cavity, nasal passageway or sinuses to be treated; said generating means are adapted to vibrate said attaching means, to vibrate the location adjacent to said nasal cavity or sinuses and thus improved mucociliary clearance of secretions in nasal cavity or sinuses.
38 . The device according to claim 37 , wherein the vibrating means comprises a motor, a power source, at least one wheel for transporting the power generated by the motor to a circular movement rotating cogwheels and at least one weight, the position there between generates a torque translated into vibrations to be transported to a plate or membrane.
39 . The device according to claim 38 , wherein said cogwheels hit a rigid material with at least every one rotation, the impact on the rigid material generates vibrations to be transported to a plate or membrane.
40 . The device according to claim 38 , wherein the vibrating means comprises a motor, a power source and a rotor in communication with an axle rotating coaxially, said rotation being translated to a vibration and further being delivered to body portion adjacent sinuses of the patient.
41 . The device according to claim 37 , wherein the vibrating means comprising an electrical or electro-magnetic motor.
42 . The device according to claim 37 , additionally comprising means of forcing a stream of fluid towards the patient's respiration tracks and/or medicament dispersing means further wherein the medicament delivery is provided by 2D or 3D specific and predetermined fitting mechanism between the capsule and the device's envelope, or by any other physical parameter.
43 . The device according to claim 42 , wherein the fluid is air or a mixture of air and at least one liquid, gas or solid powder other than air.
44 . The device according to claim 37 , additionally comprising heating means adapted to heat said fluid before or in the process of forcing it towards the respiratory tracts.
45 . The device according to claim 42 , additionally comprising activating means adapted to activate a medicament by reacting it with one or more reactants before or in the process of forcing the same towards the respiratory tracts.
46 . The inhalator as defined in claim 37 , wherein the medicament is at least partially contained in a capsule.
47 . The device according to claim 37 , additionally comprising one or more dispensing means being either active or passive means, adapted to force or purge at least a portion of the dispersed material towards a predetermined, e.g. focused target being either adjacent to the invented device or located in a remote location.Join the waitlist — get patent alerts
Track US2008200848A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.